These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 101467)

  • 21. Pseudomonas aeruginosa infection and vaccination in the rat.
    Kostiala AA
    J Med Microbiol; 1980 May; 13(2):201-12. PubMed ID: 6770090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The protective activity of 2 normal immunoglobulin preparations for intravenous administration in experimental Pseudomonas aeruginosa infection].
    Vasilev ChL; Veleva KV; Tekelieva RKh; Pencheva PI
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Feb; (2):54-6. PubMed ID: 1907793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Results of using polyvalent Pseudomonas aeruginosa vaccine in children with burns by various medical centers].
    Bbukowska D; Serafińska D; Rudowski W; Hoffman S; Olański W; Gardzińska E; Popiel D; Jedrzejczak G; Czarnecka I
    Pol Tyg Lek; 1989 Oct 23-Nov 6; 44(43-45):924-7. PubMed ID: 2518666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Passive immunization against Pseudomonas with a ribosomal vaccine-induced immune serum and immunoglobulin fractions.
    Lieberman MM; McKissock DC; Wright GL
    Infect Immun; 1979 Feb; 23(2):509-21. PubMed ID: 106013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contribution of humoral and cellular factors to the resistance to experimental infection by Pseudomonas aeruginosa in mice. I. Interaction between immunoglobulins, heat-labile serum factors, and phagocytic cells in the killing of bacteria.
    Bjornson AB; Michael JG
    Infect Immun; 1971 Oct; 4(4):462-7. PubMed ID: 5005303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mannose-modified chitosan microspheres enhance OprF-OprI-mediated protection of mice against Pseudomonas aeruginosa infection via induction of mucosal immunity.
    Cui Z; Han D; Sun X; Zhang M; Feng X; Sun C; Gu J; Tong C; Lei L; Han W
    Appl Microbiol Biotechnol; 2015 Jan; 99(2):667-80. PubMed ID: 25381907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prophylactic effects of human IgG derived from sera containing high anti-PcrV titers against pneumonia-causing Pseudomonas aeruginosa.
    Kinoshita M; Kato H; Yasumoto H; Shimizu M; Hamaoka S; Naito Y; Akiyama K; Moriyama K; Sawa T
    Hum Vaccin Immunother; 2016 Nov; 12(11):2833-2846. PubMed ID: 27454613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intranasal Peptide-Based FpvA-KLH Conjugate Vaccine Protects Mice From
    Sen-Kilic E; Blackwood CB; Boehm DT; Witt WT; Malkowski AC; Bevere JR; Wong TY; Hall JM; Bradford SD; Varney ME; Damron FH; Barbier M
    Front Immunol; 2019; 10():2497. PubMed ID: 31708925
    [No Abstract]   [Full Text] [Related]  

  • 29. [Production and experimental testing of the polyvalency of corpuscular vaccine for the prevention of Pseudomonas aeruginosa infections II. Experimental testing of the immunogenicity of polyvalent corpuscular Pseudomonas aeruginosa vaccine].
    Moroz AF; Antsiferova NG; Radkevich SA; Mishina VS
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Oct; (10):74-80. PubMed ID: 6800165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A live-attenuated Pseudomonas aeruginosa vaccine elicits outer membrane protein-specific active and passive protection against corneal infection.
    Zaidi TS; Priebe GP; Pier GB
    Infect Immun; 2006 Feb; 74(2):975-83. PubMed ID: 16428743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection against infection with Pseudomonas aeruginosa by passive transfer of monoclonal antibodies to lipopolysaccharides and outer membrane proteins.
    Sawada S; Suzuki M; Kawamura T; Fujinaga S; Masuho Y; Tomibe K
    J Infect Dis; 1984 Oct; 150(4):570-6. PubMed ID: 6436393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of OEP-antibodies in Pseudomonas aeruginosa infection.
    Doi T; Nakajima T
    Jpn J Exp Med; 1978 Aug; 48(4):287-95. PubMed ID: 101701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IL17-Producing γδ T Cells May Enhance Humoral Immunity during Pulmonary
    Pan T; Tan R; Li M; Liu Z; Wang X; Tian L; Liu J; Qu H
    Front Cell Infect Microbiol; 2016; 6():170. PubMed ID: 27999768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunization with the ferric iron-binding periplasmic protein HitA provides protection against Pseudomonas aeruginosa in the murine infection model.
    Elhosary MA; Bahey-El-Din M; AbdelBary A; El Guink N; Aboushleib HM
    Microb Pathog; 2019 Jun; 131():181-185. PubMed ID: 30978430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of cyclophosphamide on the immune response to Pseudomonas aeruginosa in mice.
    Pierson CL; Johnson AG; Feller I
    Infect Immun; 1976 Jul; 14(1):168-77. PubMed ID: 820641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective activity of an intravenous immune globulin (human) enriched in antibody against lipopolysaccharide antigens of Pseudomonas aeruginosa.
    Collins MS; Roby RE
    Am J Med; 1984 Mar; 76(3A):168-74. PubMed ID: 6424446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of cytophilic IgG3 antibody in T cell-mediated resistance to infection with the extracellular bacterium, Pseudomonas aeruginosa.
    Markham RB; Pier GB; Schreiber JR
    J Immunol; 1991 Jan; 146(1):316-20. PubMed ID: 1898604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Active and passive immunity against Pseudomonas aeruginosa with a ribosomal vaccine and antiserum in C3H/HeJ mice.
    Lieberman MM; Ayala E
    J Immunol; 1983 Jul; 131(1):1-3. PubMed ID: 6408166
    [No Abstract]   [Full Text] [Related]  

  • 39. Neutralizing antibody to Pseudomonas aeruginosa exotoxin in human sera: evidence for in vivo toxin production during infection.
    Pollack M; Callahan LT; Taylor NS
    Infect Immun; 1976 Oct; 14(4):942-7. PubMed ID: 825470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pseudomonas aeruginosa antibodies in human plasma.
    Doi T; Yoshioka M; Nakajima T
    Jpn J Exp Med; 1976 Jun; 46(3):149-54. PubMed ID: 60502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.